Schedule II
A DEA controlled substance category for compounds with accepted medical uses but high abuse potential, requiring strict regulatory controls for research and prescription use.
Definition
Schedule II is the second most restrictive category under the Controlled Substances Act, covering substances that have currently accepted medical uses but carry high potential for abuse that may lead to severe psychological or physical dependence. Examples include opioids (oxycodone, morphine), stimulants (amphetamine, methylphenidate), and some anesthetics. Research use of Schedule II substances requires DEA researcher registration, specific handling and storage procedures, paper prescriptions (no refills), and detailed record-keeping. Schedule II represents the highest DEA scheduling category for substances with accepted medical utility.
Research Context
Schedule II classification context is useful for researchers to understand the regulatory spectrum from unscheduled research compounds to heavily controlled scheduled substances. Research peptides available from Spartan Peptides are not Schedule II substances and are therefore not subject to the storage, record-keeping, and DEA registration requirements that apply to Schedule II research chemicals. This distinction is relevant when researchers work within laboratory settings that also handle scheduled substances, as different regulatory frameworks apply to different compounds in the same research environment.
Relevant Compounds
This term applies to the following research compound hubs.
Frequently Asked Questions
Explore the Research Library
Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.